This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Inoue, M. Articles by Marx, A. Search for Related Content PubMed PubMed Citation Articles by Inoue, M. Articles by Marx, A.

Correlating Genetic Aberrations with World Health Organization-defined Histology and Stage across the Spectrum of Thymomas¹

Institute of Pathology, University of Würzburg, D-97080 Würzburg, Germany [M. I., P. Sta., A. Z., P. Str., S. S., H-K. M-H., A. M.]; Department of Neuropathology, Institute for Neurology, University College London, London WC1N 3BG, United Kingdom [F. S.]; Charing Cross Hospital, London W6 8RF, United Kingdom [K. H.]; and Neuroscience Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom [N. W.]

Thymomas are thymic epithelial tumors. Because most of them are rich in nonneoplastic T-cells, recurrent genetic aberrations have been reported only in the rare, lymphocyte-poor WHO types A, B3, and C. We have now investigated virtually the whole spectrum of thymomas, including the commoner types AB and B2, microdissecting or culturing neoplastic cells from these lymphocyte-rich thymomas and applying 41 microsatellite markers covering 17 loci on 10 chromosomes. In 28 cases, comparative genomic hybridization data were available. Apart from type A, there was striking heterogeneity between thymomas. Allelic imbalances were seen in 87.3% of the 55 cases, and MSI in 9.9%. Losses of heterozygosity (LOHs) were much the commonest aberration. Overall, they were most prevalent at four regions on chromosome 6. Aberrations elsewhere, affecting mainly 8p11.21 and 7p15.3, suggested a cortical footprint because they recurred only in the thymopoietically active type AB and B thymomas. LOHs were also seen at the adenomatous polyposis coli (APC) locus (5q21-22) in subsets of these thymomas, whereas combined LOHs at the APC, retinoblastoma (13q14.3), and p53 (17p13.1) loci were confined to a subset of B3 thymomas that had possibly evolved from APC-hemizygous B2 thymomas by tumor progression; indeed, thymomas combing B2 plus B3 features are common. Notably, some AB and B thymomas shared LOHs despite their nonoverlapping morphology and different clinical behavior. Finally, allelic imbalances at 8p11.21 and 16q22.1 (CDH1) were significantly more frequent in stage IV metastatic thymomas. We conclude that the WHO-defined histological thymoma types generally segregate with characteristic genetic features, type A thymomas being the most homogeneous. Many findings support the view that B2 and B3 thymomas form a continuum, with evidence of tumor progression. However, other findings imply that types A and AB are biologically distinct from the others, any potential invasiveness being severely restricted by a medullary commitment in the precursor cell undergoing neoplastic transformation.

This article has been cited by other articles:

				T. Mori, H. Nomori, K. Ikeda, M. Yoshioka, H. Kobayashi, K. Iwatani, K. Yoshimoto, and K.-I. Iyama Three Cases of Multiple Thymoma with a Review of the Literature Jpn. J. Clin. Oncol., February 1, 2007; 37(2): 146 - 149. [Abstract] [Full Text] [PDF]

				C. Zisis, D. Rontogianni, C. Tzavara, K. Stefanaki, A. Chatzimichalis, A. Loutsidis, K. Iliadis, A. Kontaxis, T. Dosios, and I. Bellenis Prognostic Factors in Thymic Epithelial Tumors Undergoing Complete Resection Ann. Thorac. Surg., September 1, 2005; 80(3): 1056 - 1062. [Abstract] [Full Text] [PDF]